About
Max Kholin is a co-founder and senior business executive at Gero, a longevity therapeutics company using physics-informed AI and large-scale health data to develop drugs for age-related disease. Gero's current team page describes him as Chief Corporate Development Officer responsible for corporate affairs, legal strategy, fundraising, and investor relations. Earlier public materials, including a VitaDAO assessment, described him as co-founder and COO with a background in law, finance, and biotech operations.
Areas of interest
longevitybiotechdrug discoveryAI in healthcareage-related diseasehealthspan